369 related articles for article (PubMed ID: 11007511)
1. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.
Franzius C; Sciuk J; Daldrup-Link HE; Jürgens H; Schober O
Eur J Nucl Med; 2000 Sep; 27(9):1305-11. PubMed ID: 11007511
[TBL] [Abstract][Full Text] [Related]
2. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Franzius C; Daldrup-Link HE; Sciuk J; Rummeny EJ; Bielack S; Jürgens H; Schober O
Ann Oncol; 2001 Apr; 12(4):479-86. PubMed ID: 11398879
[TBL] [Abstract][Full Text] [Related]
4. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.
Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW
Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.
Franzius C; Sciuk J; Brinkschmidt C; Jürgens H; Schober O
Clin Nucl Med; 2000 Nov; 25(11):874-81. PubMed ID: 11079583
[TBL] [Abstract][Full Text] [Related]
7. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
[TBL] [Abstract][Full Text] [Related]
8. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I
Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719
[TBL] [Abstract][Full Text] [Related]
9.
Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging.
Franzius C; Daldrup-Link HE; Wagner-Bohn A; Sciuk J; Heindel WL; Jürgens H; Schober O
Ann Oncol; 2002 Jan; 13(1):157-60. PubMed ID: 11863097
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.
Daldrup-Link HE; Franzius C; Link TM; Laukamp D; Sciuk J; Jürgens H; Schober O; Rummeny EJ
AJR Am J Roentgenol; 2001 Jul; 177(1):229-36. PubMed ID: 11418435
[TBL] [Abstract][Full Text] [Related]
12. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
[TBL] [Abstract][Full Text] [Related]
16. Multiple skeletal metastases of Ewing's sarcoma demonstrated on FDG-PET and compared with bone and gallium scans.
Hung GU; Tan TS; Kao CH; Wang SJ
Kaohsiung J Med Sci; 2000 Jun; 16(6):315-8. PubMed ID: 11584433
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
[TBL] [Abstract][Full Text] [Related]
18. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
Sahin E; Zincirkeser S; Akcan AB; Elboga U
J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.
Newman EN; Jones RL; Hawkins DS
Pediatr Blood Cancer; 2013 Jul; 60(7):1113-7. PubMed ID: 23192939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
